Read More Healthcare Industry News Illumina secures FDA approval for comprehensive cancer test and two companion diagnostics Illumina, Inc. (NASDAQ: ILMN), a global leader in the field of DNA sequencing and array-based technologies, has secured… byPallavi MadhirajuAugust 27, 2024